| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.263 | 310 | 913 | 15.059 | 0 |
| Total Income - EUR | - | - | - | - | - | 2.263 | 310 | 913 | 15.059 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 1.287 | 162 | 15 | 1.562 | 229 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 976 | 148 | 897 | 13.497 | -229 |
| Net Profit/Loss - EUR | - | - | - | - | - | 908 | 139 | 870 | 11.452 | -229 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tsm Alergoimun S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.533 | 1.634 | 1.970 | 14.204 | 13.774 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 35 | 48 | 379 | 9.758 | 11.002 |
| Cash | - | - | - | - | - | 1.498 | 1.585 | 1.590 | 4.445 | 2.773 |
| Shareholders Funds | - | - | - | - | - | 950 | 1.068 | 1.941 | 13.387 | 13.083 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 583 | 566 | 29 | 817 | 691 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tsm Alergoimun S.r.l.